Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12898087 | 1.00 | MAPT (0.56) | MAPTALDH1A1SMN1; SMN2CYP3A4CYP2D6 | |
| SCHEMBL12898753 | 1.00 | MAPT (0.56) | MAPTALDH1A1SMN1; SMN2CYP3A4CYP2D6 | |
| Hydrochloric Acid SCHEMBL28542417 | 0.98 | MAPT (0.54) | MAPTALDH1A1SMN1; SMN2CYP3A4CYP2D6 | |
| Hydrochloric Acid SCHEMBL28542420 | 0.98 | MAPT (0.54) | MAPTALDH1A1SMN1; SMN2CYP3A4CYP2D6 | |
| SCHEMBL12885924 | 0.89 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2CYP2C19HPGDHTT | |
| SCHEMBL12310224 | 0.89 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2CYP2C19HPGDHTT | |
| SCHEMBL153251 | 0.89 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2CYP2C19HPGDHTT | |
| SCHEMBL446501 | 0.89 | MAPT (0.64) | MAPTALDH1A1SMN1; SMN2CYP3A4CYP2D6 | |
| Hydrochloric Acid SCHEMBL9704969 | 0.87 | MAPT (0.62) | MAPTALDH1A1SMN1; SMN2CYP3A4CYP2D6 | |
| Iodide SCHEMBL30309834 | 0.87 | MAPT (0.62) | MAPTALDH1A1SMN1; SMN2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021072140-A1 | PRODRUGS OF MYELOPEROXIDASE INHIBITORS | BIOHAVEN THERAPEUTICS LTD. (US) | 2021-04-15 | — | — | WO | disclosed |
| EP-3033336-B1 | INHIBITORS OF PLASMA KALLIKREIN | KALVISTA PHARMACEUTICALS LTD (GB) | 2018-05-30 | — | — | EP | disclosed |
| EP-0874809-B1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 2003-08-27 | — | — | EP | disclosed |
| EP-1242400-A1 | PYRROLIDINE DERIVATIVES AS CYCLIC AMP-SPECIFIC PHOSPHODIESTERASE INHIBITORS | ICOS CORPORATION (US) | 2002-09-25 | — | — | EP | disclosed |
| WO-2001047905-A1 | PYRROLIDINE DERIVATIVES AS CYCLIC AMP-SPECIFIC PHOSPHODIESTERASE INHIBITORS | ICOS CORPORATION (US) | 2001-07-05 | — | — | WO | disclosed |
| US-6239175-B1 | Carbamoyloxy derivatives of mutiline and their use as antibacterials | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-05-29 | — | — | US | disclosed |
| US-6020368-A | MICROBIOCIDES | HINKS JEREMY DAVID (US) | 2000-02-01 | — | — | US | disclosed |
| EP-0874809-A1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 1998-11-04 | — | — | EP | disclosed |
| WO-1997025309-A1 | CARBAMOYLOXY DERIVATIVES OF MUTILINE AND THEIR USE AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 1997-07-17 | — | — | WO | disclosed |
| US-4585865-A | INTERMEDIATES FOR ANTICHOLINERGIC AGENTS | FMC CORPORATION (US) | 1986-04-29 | — | — | US | disclosed |
| US-4584378-A | MYDRIATIC AGENTS | FMC CORPORATION (US) | 1986-04-22 | — | — | US | disclosed |
| US-4467095-A | Anticholinergic compounds | FMC CORPORATION (US) | 1984-08-21 | — | — | US | disclosed |